Skip to main content
High RiskFDAfda-F-0666-2025MISLABELED

COFFEE ROASTERS Our Family TRAVERSE CITY CHERRY ARTIFICIALLY FLAVORED DECAF LIGHT ROAST GROUND COFFEE NET WT 12 OZ (340g) UPC 0 70253 110...

Category
Units Affected
692
Recall Date
March 13, 2025
Issuing Agency
Hazard
Mislabeled

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0666-2025.

Mislabeling. A portion of the production of Our Family Traverse City Ground Coffee was mislabeled as decaffeinate.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0666-2025.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Massimo Zanetti Beverage Usa or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0666-2025.

Massimo Zanetti Beverage USA

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Massimo Zanetti Beverage Usa Recall FAQ

Massimo Zanetti Beverage Usa is the subject of a beverages safety report: COFFEE ROASTERS Our Family TRAVERSE CITY CHERRY ARTIFICIALLY FLAVORED DECAF LIGHT ROAST GROUND COFFEE NET WT 12 OZ (340g) UPC 0 70253 110.... The notice was published on March 13, 2025 by the U.S. Food and Drug Administration (FDA). Approximately 692 units are potentially affected.